XML 27 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900
Inventory
 12 Months Ended
Dec. 31, 2015
Inventory

3. Inventory

All of the Company’s inventories relate to the manufacturing of Iclusig. The following table sets forth the Company’s inventories as of December 31, 2015 and 2014:

 

In thousands    2015      2014  

Raw materials

    $ 813       $ —     

Work in process

      89         460   

Finished goods

      1,007         979   
  

 

 

     

 

 

  

Total

      1,909         1,439   

Current portion

      (1,096 )       (979 ) 
  

 

 

     

 

 

  

Non-current portion included in intangible and other assets, net

    $ 813       $ 460   
  

 

 

     

 

 

  

The Company has not capitalized inventory costs related to its other drug development programs. Non-current inventory consists of work-in-process inventory that was manufactured in order to provide adequate supply of Iclusig in the United States and Europe and to support continued clinical development.